Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis.
Haworth
C S
CS
Selby
P L
PL
Webb
A K
AK
Mawer
E B
EB
Adams
J E
JE
Freemont
T J
TJ
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects; D001847:Bone Diseases / Q000139:chemically induced*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D010146:Pain / Q000139:chemically induced*; D000077268:Pamidronate
D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D000077268:Pamidronate